https://www.indianpharmapost.com/alkem-licenses-technology-from-harvard-to-treat-ischemic-injury-and-vascular-diseases-114812022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/sinocompound-announces-commercial-scale-production-of-qphos-ligand-114932022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-kgaa-reports-higher-profits-on-strong-volumes-across-its-businesses-114922022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/masina-hospital-opens-a-new-dialysis-centre-114912022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/medix-biochemica-announces-expansion-of-its-porfolio-114902022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-usfda-approval-for-topical-solution-114892022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/avenge-bio-announces-peer-reviewed-publication-on-preclinical-proof-of-concept-for-lococyte-platform-technology-114882022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/who-includes-molnupiravir-in-its-covid-19-treatment-guidelines-114872022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/ihub-data-and-iiit-hyderabad-offer-course-on-drug-discovery-114862022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/limited-impact-of-short-term-disruptions-growth-momentum-to-continue-in-fy-23-114852022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/iifl-amc-funds-acquire-stake-in-omniactive-health-technologies-114842022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/brinton-ties-up-with-scholl-wellness-company-114832022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-gets-approval-from-sec-to-conduct-paxlovid-trials-114822022-03-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/dcgi-approves-themis-medicares-viralex-for-covid-19-treatment-114942022-03-03T00:00:00+05:30always0.9